matterfact
Marketecture: Get Smart. Fast.
3w ago·58m
Episode 177: Scott Ensign of Butler/Till on Innovation at Indy Agencies
Scott Ensign, Chief Strategy Officer at Butler/Till, joins Ari Paparo to discuss the advantages of being a 100% employee-owned agency, the rise of agentic AI in media buying, AdCP adoption, and the future of pharmaceutical advertising. Learn how Butler/Till is leveraging AI-powered workflows, healthcare expertise, mobile gaming inventory, and programmatic innovation to drive growth in a rapidly evolving media landscape.
Takeaways
Butler/Till operates as a 100% employee-owned ESOP, giving employees ownership stakes and allowing the agency to remain independent and agile.
The agency is a women-owned and women-led business, with roughly two-thirds of employees being women.
Thanks to its status as an independent agency, Butler/Till can operate with agility, making faster decisions and investing strategically without outside shareholder pressure.
Butler/Till takes a product-focused approach, building technology and solutions around client needs rather than creating products solely for commercialization.
Pharmaceutical advertising is shifting away from broad-reach TV campaigns toward addressable, data-driven digital media channels.
Even if pharmaceutical advertising regulations change, opportunities will remain through disease-state education and targeted healthcare professional outreach.
Mobile gaming remains an undervalued advertising channel, particularly for reaching healthcare professionals during everyday moments.
Butler/Till participated in one of the industry's earliest agentic AI-powered media transactions using AdCP technology.
Agentic AI can automate traditionally manual workflows such as RFPs, publisher negotiations, and media planning.
The agency views AI primarily as a tool for accelerating work and solving talent shortages rather than replacing employees.
Chapters00:00 Introduction to Scott Ensign and Butler/Till00:41 What makes Butler/Till unique as an employee-owned agency01:24 The history behind Butler/Till's ESOP structure02:25 Independent agencies vs. holding companies03:47 Product development and technology investments at Butler/Till04:33 Why Butler/Till hired a Chief Product Officer05:08 How clients approach AI and workflow innovation06:33 The changing landscape of pharmaceutical advertising08:31 Regulatory concerns and the future of pharma marketing10:44 Reaching healthcare professionals in the digital age12:15 Why mobile gaming is an overlooked advertising opportunity14:19 Butler/Till's early agentic AI and AdCP media transaction16:25 How buyer and seller AI agents could negotiate media deals19:28 Why pharma is a strong fit for agentic media buying21:24 Expanding AdCP into audio and offline media channels23:01 AI, efficiency, and the future of agency work23:57 Butler/Till's growth, hiring plans, and closing thoughts
Guests: Ari Paparo, Scott Ensign
Learn more about your ad choices. Visit megaphone.fm/adchoices
Takeaways
Butler/Till operates as a 100% employee-owned ESOP, giving employees ownership stakes and allowing the agency to remain independent and agile.
The agency is a women-owned and women-led business, with roughly two-thirds of employees being women.
Thanks to its status as an independent agency, Butler/Till can operate with agility, making faster decisions and investing strategically without outside shareholder pressure.
Butler/Till takes a product-focused approach, building technology and solutions around client needs rather than creating products solely for commercialization.
Pharmaceutical advertising is shifting away from broad-reach TV campaigns toward addressable, data-driven digital media channels.
Even if pharmaceutical advertising regulations change, opportunities will remain through disease-state education and targeted healthcare professional outreach.
Mobile gaming remains an undervalued advertising channel, particularly for reaching healthcare professionals during everyday moments.
Butler/Till participated in one of the industry's earliest agentic AI-powered media transactions using AdCP technology.
Agentic AI can automate traditionally manual workflows such as RFPs, publisher negotiations, and media planning.
The agency views AI primarily as a tool for accelerating work and solving talent shortages rather than replacing employees.
Chapters00:00 Introduction to Scott Ensign and Butler/Till00:41 What makes Butler/Till unique as an employee-owned agency01:24 The history behind Butler/Till's ESOP structure02:25 Independent agencies vs. holding companies03:47 Product development and technology investments at Butler/Till04:33 Why Butler/Till hired a Chief Product Officer05:08 How clients approach AI and workflow innovation06:33 The changing landscape of pharmaceutical advertising08:31 Regulatory concerns and the future of pharma marketing10:44 Reaching healthcare professionals in the digital age12:15 Why mobile gaming is an overlooked advertising opportunity14:19 Butler/Till's early agentic AI and AdCP media transaction16:25 How buyer and seller AI agents could negotiate media deals19:28 Why pharma is a strong fit for agentic media buying21:24 Expanding AdCP into audio and offline media channels23:01 AI, efficiency, and the future of agency work23:57 Butler/Till's growth, hiring plans, and closing thoughts
Guests: Ari Paparo, Scott Ensign
Learn more about your ad choices. Visit megaphone.fm/adchoices
Start Free Trial14 days free
Transcript
The full transcript is available with a free trial.
This is one of 120M+ episodes across 700K+ channels — fully transcribed, searchable, and queryable with AI on Matterfact.
14 days freeCancel anytime
Full transcriptsAI Q&ADeep search
Why Matterfact
Built for investment professionals
Executives are more candid on podcasts than earnings calls. Matterfact makes those conversations searchable, readable, and queryable with AI.
120M+episodes transcribed
Jensen Huang: "The demand for accelerated computing is incredible..."
Host: "How do you see AI changing the semiconductor landscape?"
Jensen: "Every data center is going to be accelerated..."
Start your free trial
Every day you wait, your competitors are finding
edge in conversations you're not hearing.
Full access to 120M+ transcribed episodes, AI-powered search, and unlimited Q&A — free for 14 days.
14 days free · Cancel anytime